Northwestern Mutual Wealth Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11
Closed -$11 3724
2023
Q3
$11 Buy
+11
New +$8 ﹤0.01% 3252
2022
Q3
Hold
0
3478
2022
Q2
Hold
0
3558
2022
Q1
Hold
0
3496
2021
Q4
Hold
0
3401
2021
Q3
Hold
0
3274
2021
Q2
Hold
0
3198
2021
Q1
Hold
0
3007
2020
Q4
Hold
0
2929
2020
Q3
Hold
0
2712
2020
Q2
Hold
0
2747
2020
Q1
Hold
0
2797
2019
Q4
Hold
0
2672
2019
Q3
Hold
0
2733
2019
Q2
Hold
0
2759
2019
Q1
Hold
0
2733
2018
Q4
Hold
0
2704
2018
Q3
Hold
0
2666
2018
Q2
Hold
0
2524
2018
Q1
Hold
0
2467
2017
Q4
Hold
0
2483
2017
Q3
Hold
0
2295
2017
Q2
Hold
0
2194
2017
Q1
Hold
0
2478

Other funds holding FRTX

Northwestern Mutual Wealth Management's FRTX Position: Q4 2023 in Review

Northwestern Mutual Wealth Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 11 shares — an estimated $11 sold.

Northwestern Mutual Wealth Management first reported a position in FRTX in Q3 2023 and held it in 1 quarter. The position peaked at $11 in Q3 2023. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.

  • Northwestern Mutual Wealth Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 11 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $11.
  • Northwestern Mutual Wealth Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $11 in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.